In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides Public Deposited

http://ir.library.oregonstate.edu/concern/articles/p2677122v

This is an author's peer-reviewed final manuscript, as accepted by the publisher. The published article is copyrighted by Bentham Science Publishers and can be found at:  http://www.benthamscience.com/cpd/.

Descriptions

Attribute NameValues
Creator
Abstract or Summary
  • Morpholino oligos (Morpholinos) are widely used tools for knocking down gene expression and are currently in a clinical trial for treatment of Duchene muscular dystrophy. A Morpholino analog has been in a clinical trial as a potential anti-bioterrorism agent for inhibiting replication of deadly Marburg viral infection. The cellular uptake of Morpholinos can been greatly increased by conjugation with cell-penetrating peptides (CPP). The use of the CPP-Morpholino conjugates (PPMOs) in vivo has been broadly demonstrated in viral, bacterial, genetic and other diseases. The following aspects of PPMOs will be discussed in this paper including chemistry, stability, antisense specificity, mechanism of cellular uptake, in vivo efficacy, tissue distribution, pharmacokinetics, toxicity and the human clinical trials. PPMOs are powerful research tools for studying gene function in animals and their properties are being improved as potential human therapeutic agents.
Resource Type
DOI
Date Available
Date Issued
Citation
  • Moulton, H. (2013). In vivo delivery of morpholino oligos by cell-penetrating peptides. Current Pharmaceutical Design, 19(16), 2963-2969.
Academic Affiliation
Series
Keyword
Rights Statement
Publisher
Peer Reviewed
Language
Replaces

Relationships

Parents:

This work has no parents.

Last modified

Downloadable Content

Download PDF

Items